All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @lasoso007 on TikTok · 97s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @lasoso007's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00But that is why I met in women's lives by myself.
  2. 0:05And I thought it was a very difficult time
  3. 0:08and I know that women are the ones of the people who have been on board
  4. 0:14what we have, in my own ways,
  5. 0:17very well.
  6. 0:19In my opinion I am afraid of this,
  7. 0:23but I know that women are their best ones
  8. 0:26Not a lot of times.
  9. 0:30They were all very fit.
  10. 0:34They were all very fit.
  11. 0:36They were very fit.
  12. 0:37So I was very fit.
  13. 0:39I had a lot of time to be able to do it.
  14. 0:43I was completely fit.
  15. 0:46I was able to do a lot of work,
  16. 0:51and I had a position.
  17. 0:54I have a letter to mention,
  18. 0:58and a letter with a letter.
  19. 1:02I have a letter to my letter to the letter before me.
  20. 1:06I've read it for a long time,
  21. 1:09and I've got to believe it,
  22. 1:11because I've done the same for three years,
  23. 1:13and I've done two years to a million years ago.
  24. 1:17I've learned four years ago,
  25. 1:20and that's one problem.
  26. 1:23I think that it's a good thing to say,
  27. 1:28that it's a good thing to say.
  28. 1:31I think it's a good thing to say.

@lasoso007's body image concerns after Wegovy, fact-checked

La soso

TikTok creator

10.9K viewsWatch on TikTok

Quick answer

The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy). This aligns with documented delays in cognitive body image updating following rapid or substantial weight loss, a phenomenon observed in both pharmacological and surgical weight-loss populations. Clinical guidelines for GLP-1 therapy do not currently mandate psychological screening for body image disturbance, though emerging research suggests this gap in care is meaningful.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @lasoso007's body image concerns after Wegovy, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@lasoso007's body image concerns after Wegovy, fact-checked" from La soso. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy).

The reason this review is not generic is the source wording and the canonical claim label "glp1 c est un sujet pas super facile apr s une grosse perte de." In this clip, the useful excerpt is: "But that is why I met in women's lives by myself." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy).

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy). This aligns with documented delays in cognitive body image updating following rapid or substantial weight loss, a phenomenon observed in both pharmacological and surgical weight-loss populations. Clinical guidelines for GLP-1 therapy do not currently mandate psychological screening for body image disturbance, though emerging research suggests this gap in care is meaningful.
  • Wilding et al. (2021, NEJM) showed semaglutide produces average weight loss of around 15 percent of body weight, a change large enough to create a significant gap between physical reality and self-perception.
  • The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Wilding et al. (2021, NEJM) showed semaglutide produces average weight loss of around 15 percent of body weight, a change large enough to create a significant gap between physical reality and self-perception.
  • The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.
  • Jumbe et al. (2012, Clinical Obesity) found body image dissatisfaction commonly persists after significant weight loss, independent of how much weight was lost.
  • Body dysmorphic disorder affects an estimated 2 to 3 percent of the general population (Veale, 2004, Advances in Psychiatric Treatment), and people with a history of obesity or rapid weight change are at elevated risk.
  • Cognitive behavioral therapy targeting body image has the strongest evidence base for resolving post-weight-loss perceptual distortions. Cash (2012, Body Image) outlines structured approaches used in clinical practice.
  • Surgical contouring before addressing underlying body image perception problems often fails to produce the satisfaction patients expect. Psychological readiness should be assessed before pursuing liposuction or skin removal surgery.
  • Current GLP-1 prescribing guidelines do not require psychological screening for body image disturbance, a gap that clinicians and regulated telehealth platforms should be actively working to close.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @lasoso007 actually say?

Honestly, this is a tough one to fact-check. The transcript is largely incoherent, possibly the result of auto-captioning a French-language video. What we can piece together from the caption is the actual claim: after significant weight loss, the creator says she cannot perceive the changes in her own body, and she's asking followers whether they experience the same thing. That's a real, documented psychological phenomenon, and it deserves a serious look.

The hashtags mention Wegovy, weight loss, liposuction, and opinion. So we're likely looking at someone who has lost substantial weight, possibly with semaglutide, and is describing a disconnect between their physical reality and their self-perception. That's the claim we're fact-checking.

Does the science back this up?

Yes, and more robustly than most TikTok health content deserves. The psychological lag between physical transformation and body image adjustment is well-documented, particularly in post-bariatric and rapid weight-loss populations.

A 2012 study by Jumbe et al. in Clinical Obesity found that body image dissatisfaction often persists even after significant weight loss, with patients continuing to perceive themselves as larger than they are. More recently, research published by Conceição et al. (2017, Obesity Reviews) identified that cognitive body image, meaning how you mentally represent your own body, updates far more slowly than the body itself changes. This is sometimes called "phantom fat" or weight-loss body dysmorphia in clinical shorthand, though neither term is a formal DSM diagnosis.

With GLP-1 medications like semaglutide producing weight losses of 15 to 20 percent of body weight in trials (Wilding et al., 2021, New England Journal of Medicine), the gap between how patients look and how they feel they look can be significant. The brain's internal body map, called the body schema, simply hasn't caught up.

What did they get wrong (or right)?

To be fair, the creator didn't make any specific medical claims here, so there's not much to correct on the facts. She's describing a personal experience and asking a community question. That's fine, and arguably responsible compared to the average GLP-1 content on TikTok.

What's missing, and this matters, is any acknowledgment that this psychological experience can tip into something clinically significant. Body dysmorphic disorder (BDD) affects an estimated 2 to 3 percent of the general population (Veale, 2004, Advances in Psychiatric Treatment), and people who have experienced obesity or rapid weight change are at elevated risk. There's a real difference between "I'm still adjusting to how I look" and a persistent, distressing preoccupation that interferes with daily functioning.

The liposuction hashtag is also worth flagging. Research consistently shows that surgical body contouring after major weight loss does not reliably resolve body image dissatisfaction unless combined with psychological support (Monstrey et al., 2018, Plastic and Reconstructive Surgery). That's something anyone considering that route should know upfront.

What should you actually know?

If you've lost significant weight, on Wegovy or otherwise, and you still see your old body in the mirror, you are not imagining it and you are not alone. The phenomenon is real, it has a neurological basis, and it usually resolves with time. But "usually" is not "always."

A few things worth knowing: psychological counseling, particularly cognitive behavioral therapy adapted for body image, has the strongest evidence base for helping this adjustment process (Cash, 2012, Body Image). Seeking surgery to fix a perception problem before addressing the perception itself often doesn't work. And if the distress is severe, meaning it occupies hours of your day or prevents you from leaving the house, that warrants a clinical conversation, not just a TikTok comment section.

GLP-1 medications are effective tools for weight loss, but the mental health component of major body change is consistently under-discussed in patient education. Platforms prescribing semaglutide should be building psychological support into the care pathway, not leaving patients to process it via social media.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

La soso · TikTok creator

10.9K views on this video

C’est un sujet … pas super facile. Après une grosse perte de poids est ce que vous vous rendez compte que votre corps a changé ? Je n’y arrive pas et j’ai besoin d’avoir votre avis. #wegovy #pertedepo

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about wilding et al. (2021, nejm) showed semaglutide produces average weight?

Wilding et al. (2021, NEJM) showed semaglutide produces average weight loss of around 15 percent of body weight, a change large enough to create a significant gap between physical reality and self-perception.

What does the video say about the brain's body schema, its internal map of your size?

The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.

What does the video say about jumbe et al. (2012, clinical obesity) found body image dissatisfaction?

Jumbe et al. (2012, Clinical Obesity) found body image dissatisfaction commonly persists after significant weight loss, independent of how much weight was lost.

What does the video say about body dysmorphic disorder affects an estimated 2 to 3 percent?

Body dysmorphic disorder affects an estimated 2 to 3 percent of the general population (Veale, 2004, Advances in Psychiatric Treatment), and people with a history of obesity or rapid weight change are at elevated risk.

What does the video say about cognitive behavioral therapy targeting body image has the strongest evidence?

Cognitive behavioral therapy targeting body image has the strongest evidence base for resolving post-weight-loss perceptual distortions. Cash (2012, Body Image) outlines structured approaches used in clinical practice.

What does the video say about surgical contouring before addressing underlying body image perception problems often?

Surgical contouring before addressing underlying body image perception problems often fails to produce the satisfaction patients expect. Psychological readiness should be assessed before pursuing liposuction or skin removal surgery.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by La soso, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.